Brief: Formycon And Zydus Partner For Exclusive Licensing And Supply Agreement Of Fyb206
Dec 9 (Reuters) - Formycon AG FYB.DE: FORMYCON AND ZYDUS PARTNER FOR EXCLUSIVE LICENSING AND SUPPLY AGREEMENT OF FYB206, A BIOSIMILAR TO KEYTRUDA® (PEMBROLIZUMAB), IN THE U.S. AND CANADA FORMYCON AG: UPON SIGNATURE OF AGREEMENT, CO TO BE ELIGIBLE TO RECEIVE MID-TEENS-MILLION-EURO UPFRONT & MILESTONE PAYMENTS IN 2025 Source text: ID:nGNX5xd11y Further company coverage: FYB.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka